Ann Lab Med.  2012 Jul;32(4):276-282. 10.3343/alm.2012.32.4.276.

Erythrocyte Binding Preference of Human Pandemic Influenza Virus A and Its Effect on Antibody Response Detection

• Makkoch J
• Prachayangprecha S
• Payungporn S
• Chieochansin T
• Songserm T
• Amonsin A
• Poovorawan Y

• KMID: 1380087
• DOI: http://doi.org/10.3343/alm.2012.32.4.276

Abstract

BACKGROUND
Validation of hemagglutination inhibition (HI) assays is important for evaluating antibody responses to influenza virus, and selection of erythrocytes for use in these assays is important. This study aimed to determine the correlation between receptor binding specificity and effectiveness of the HI assay for detecting antibody response to pandemic influenza H1N1 (pH1N1) virus.
METHODS
Hemagglutination (HA) tests were performed using erythrocytes from 6 species. Subsequently, 8 hemagglutinating units of pH1N1 from each species were titrated by real-time reverse transcription-PCR. To investigate the effect of erythrocyte binding preference on HI antibody titers, comparisons of HI with microneutralization (MN) assays were performed.
RESULTS
Goose erythrocytes showed most specific binding with pH1N1, while HA titers using human erythrocytes were comparable to those using turkey erythrocytes. The erythrocyte binding efficiency was shown to have an impact on antibody detection. Comparing MN titers, HI titers using turkey erythrocytes yielded the most accurate results, while those using goose erythrocytes produced the highest geometric mean titer. Human blood group O erythrocytes lacking a specific antibody yielded results most comparable to those obtained using turkey erythrocytes. Further, pre-existing antibody to pH1N1 and different erythrocyte species can distort HI assay results.
CONCLUSIONS
HI assay, using turkey and human erythrocytes, yielded the most comparable and applicable results for pH1N1 than those by MN assay, and using goose erythrocytes may lead to overestimated titers. Selection of appropriate erythrocyte species for HI assay allows construction of a more reliable database, which is essential for further investigations and control of virus epidemics.

Keyword

Hemagglutination test; Hemagglutination inhibition test; Erythrocyte binding preference; Microneutralization test; H1N1 virus

MeSH Terms

Adult
Animals
Antibodies, Neutralizing/immunology
Antibodies, Viral/*analysis/immunology
Chickens
Erythrocytes/*metabolism
Female
Geese
*Hemagglutination Inhibition Tests
Horses
Humans
Influenza A Virus, H1N1 Subtype/genetics/immunology/*metabolism
Influenza, Human/epidemiology/immunology/virology
Male
Middle Aged
Neutralization Tests
Pandemics
Swine
Turkeys

Reference

1. Centers for Disease Control and Prevention. Swine influenza A (H1N1) infection in two children-Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep. 2009. 58:400–402.

2. World Health Organization. Clinical management of adult patients with complications of pandemic influenza A (H1N1) 2009: emergency guidelines for the management of patients with severe respiratory distress and shock in district hospitals in limited-resource settings. 2010. Geneva, Switzerland: World Health Organization.

3. Pandemic (H1N1) 2009 - update 111. World Health Organization. Updated on Jul 2010. http://www.who.int/csr/don/2010_07_30/en/.

4. Boonsuk P, Payungporn S, Chieochansin T, Samransamruajkit R, Amonsin A, Songserm T, et al. Detection of influenza virus types A and B and type A subtypes (H1, H3, and H5) by multiplex polymerase chain reaction. Tohoku J Exp Med. 2008. 215:247–255.

5. Chieochansin T, Makkoch J, Suwannakarn K, Payungporn S, Poovorawan Y. Novel H1N1 2009 influenza virus infection in Bangkok, Thailand: effects of school closures. Asian Biomed. 2009. 3:469–475.

6. World Health Organization. WHO manual on animal influenza diagnosis and surveillance. Department of communicable disease, World Health Organization. 2002. Geneva, Switzerland: World Health Organization.

7. Klenk E, Uhlenbruck G. A neuraminic acid containing mucoprotein from cattle erythrocyte stroma. Hoppe Seyler Z Physiol Chem. 1958. 311:227–233.

8. Rogers GN, Paulson JC. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology. 1983. 127:361–373.

9. Yamakawa T, Nagai Y. Glycolipid at the cell surface and their biological functions. Trends Biochem Sci. 1978. 3:128–131.

10. Rogers GN, Paulson JC, Daniels RS, Skehel JJ, Wilson IA, Wiley DC. Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature. 1983. 304:76–78.

11. Stephenson I, Wood JM, Nicholson KG, Zambon MC. Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin. J Med Virol. 2003. 70:391–398.

12. Ito T, Suzuki Y, Mitnaul L, Vines A, Kida H, Kawaoka Y. Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology. 1997. 227:493–499.

13. Suzuki Y, Ito T, Suzuki T, Holland RE Jr, Chambers TM, Kiso M, et al. Sialic acid species as a determinant of the host range of influenza A viruses. J Virol. 2000. 74:11825–11831.

14. Chutinimitkul S, Chieochansin T, Payungporn S, Samransamruajkit R, Hiranras T, Theamboonlert A, et al. Molecular characterization and phylogenetic analysis of H1N1 and H3N2 human influenza A viruses among infants and children in Thailand. Virus Res. 2008. 132:122–131.

15. Makkoch J, Payungporn S, Prachayangprecha S, Tantilertcharoen R, Poovorawan Y. Determination of antibody response to the human pandemic influenza H1N1 2009 among patients with influenza-like illness and high risk group. Asian Pac J Allergy Immunol. 2010. 28:67–75.

16. CDC protocol of realtime RT-PCR for influenza A (H1N1). World Health Organization. Updated on Apr 2009. http://www.who.int/csr/resources/publications/swineflu/realtimeptpcr/en/index.html.

17. Prachayangprecha S, Makkoch J, Payungporn S, Chieochansin T, Vuthitanachot C, Vuthitanachot V, et al. Serological analysis of human pandemic influenza (H1N1) in Thailand. J Health Popul Nutr. 2010. 28:537–544.

18. Kendal AP, Pereira MS, Skehel JJ. Concepts and procedures for laboratory-based influenza surveillance. 1982. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control.

19. Martensson E, Raal A, Svennerholm L. Sialic acid in blood serum. Biochim Biophys Acta. 1958. 30:124–129.

20. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, et al. Cross-reactive antibody response to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009. 361:1945–1952.

21. Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW, Lu X, Lim W, et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol. 1999. 37:937–943.

22. Reed LJ, Muench H. A simple method of estimating fifty percent endpoint. Am J Hyg. 1938. 27:493–497.

23. Hara S, Takemori Y, Yamaguchi M, Nakamura M, Ohkura Y. Fluorometric high-performance liquid chromatography of N-acetyl-and N-glycolylneuraminic acids and its application to their microdetermination in human and animal sera, glycoproteins, and glycolipids. Anal Biochem. 1987. 164:138–145.

24. Naiki M. Chemical and immunochemical properties of two classes of globoside from equine organs. Jpn J Exp Med. 1971. 41:67–81.

25. Pettersson S, Sivertsson OR, Sjogren S, Svennerholm L. The sialic acids of hog pancreas. Biochim Biophys Acta. 1958. 28:444–445.

26. Schauer R, editor. Sialic acids, chemistry, metabolism, and function. 1982. New York: Springer-Verlag.

27. Varki A. Diversity in the sialic acids. Glycobiology. 1992. 2:25–40.

28. Higa HH, Rogers GN, Paulson JC. Influenza virus hemagglutinins differentiate between receptor determinants bearing N-acetyl-, N-glycollyl- and N,O-diacetylneuraminic acids. Virology. 1985. 144:279–282.

29. Connor RJ, Kawaoka Y, Webster RG, Paulson JC. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology. 1994. 205:17–23.

30. Ilyulshina NA, Kim JK, Negovetich NJ, Choi YK, Lang V, Bovin NV, et al. Extensive mammalian ancestry of pandemic (H1N1) 2009 virus. Emerg Infect Dis. 2010. 16:314–317.

31. Suzuki Y, Matsunaga M, Matsumoto M. N-Acetylneuraminyllactosylceramide, GM3-NeuAc, a new influenza A virus receptor which mediates the adsorption-fusion process of viral infection. Binding specificity of influenza virus A/A/ichi/2/68 (H3N2) to membrane-associated GM3 with different molecular species of sialic acid. J Biol Chem. 1985. 260:1362–1365.

32. Wiriyarat W, Lerdsamran H, Pooruk P, Webster RG, Louisirirotchanakul S, Ratanakorn P, et al. Erythrocyte binding preference of 16 subtypes of low pathogenic avian influenza and 2009 pandemic influenza A (H1N1) viruses. Vet Microbiol. 2010. 146:346–349.

33. Carboneras C. del Hoyo J, Elliot A, Sargatal J, editors. Family Anatidae (ducks, geese, and swans). Handbook of the birds of the world. 1992. Barcelona: Lynx Edicions;536–628.

34. Dulyachai W, Makkoch J, Rianthavorn P, Changpinyo M, Prayangprecha S, Payungporn S, et al. Perinatal pandemic (H1N1) 2009 infection, Thailand. Emerg Infect Dis. 2010. 16:343–344.